K. Romano, Akbar Ali, Cihan Aydin, Djadé Soumana, Ayşegül Özen, Laura Deveau, Casey Silver, H. Cao, Alicia Newton, C. Petropoulos, Wei Huang, C. Schiffer (2012)
The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease InhibitorsPLoS Pathogens, 8
M. Sofia, S. Alqahtani, H. Alter, R. Bartenschlager, E. Billerbeck, H. Cho, P. Furman, Y. Gai (2019)
HCV: The Journey from Discovery to a Cure: Volume IHCV: The Journey from Discovery to a Cure
(1999)
Correspondence e-mail:
S. Jean, P. Hsueh (2020)
Old and re-purposed drugs for the treatment of COVID-19Expert Review of Anti-Infective Therapy
O. Gerlits, Xiaotian Kong, Xiaolin Cheng, T. Wymore, D. Blumenthal, P. Taylor, Z. Radić, A. Kovalevsky (2019)
Productive reorientation of a bound oxime reactivator revealed in room temperature X-ray structures of native and VX-inhibited human acetylcholinesteraseThe Journal of Biological Chemistry, 294
S. Jo, Suwon Kim, D. Shin, Mi‐Sun Kim (2019)
Inhibition of SARS-CoV 3CL protease by flavonoidsJournal of Enzyme Inhibition and Medicinal Chemistry, 35
Fangfang Huang, Ying Li, E. Leung, Xiaohua Liu, Kaifeng Liu, Qu Wang, Yongqi Lan, Xiaoling Li, Haibing Yu, L. Cui, Hui Luo, Lianxiang Luo (2020)
A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19)Pharmacological Research, 158
Melika Lotfi, Michael Hamblin, N. Rezaei (2020)
COVID-19: Transmission, prevention, and potential therapeutic opportunitiesClinica Chimica Acta; International Journal of Clinical Chemistry, 508
Jon Jacobs, Valerie Grum-Tokars, Ya Zhou, M. Turlington, S. Saldanha, Peter Chase, A. Eggler, E. Dawson, Y. Báez-Santos, S. Tomar, A. Mielech, S. Baker, C. Lindsley, P. Hodder, A. Mesecar, Shaun Stau, er (2013)
Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL protease.Journal of medicinal chemistry, 56 2
Adams (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa Crystallogr. D Biol. Crystallogr., 66
P. Thanigaimalai, S. Konno, Takehito Yamamoto, Yuji Koiwai, A. Taguchi, Kentaro Takayama, F. Yakushiji, K. Akaji, Shengwu Chen, A. Naser-Tavakolian, A. Schön, E. Freire, Y. Hayashi (2013)
Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studiesEuropean Journal of Medicinal Chemistry, 68
R. Ménard, A. Storer (1992)
Oxyanion hole interactions in serine and cysteine proteases.Biological chemistry Hoppe-Seyler, 373 7
METHOD DETAILS General Information Protein purification supplies were purchased from GE Healthcare
K. Anand, J. Ziebuhr, P. Wadhwani, J. Mesters, R. Hilgenfeld (2003)
Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS DrugsScience, 300
Chunlong Ma, M. Sacco, B. Hurst, J. Townsend, Yanmei Hu, Tommy Szeto, Xiujun Zhang, Bart Tarbet, M. Marty, Yu Chen, Jun Wang (2020)
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main proteasebioRxiv
(2017)
Discovery of unsymmetrical aromtic
Emsley (2010)
Features and development of CootActa Crystallogr. D Biol. Crystallogr., 66
E. Belongia, M. Osterholm (2020)
COVID-19 and flu, a perfect stormScience, 368
D. Kneller, G. Phillips, Hugh O’Neill, R. Jedrzejczak, L. Stols, P. Langan, A. Joachimiak, L. Coates, A. Kovalevsky (2020)
Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallographyNature Communications, 11
D. Keedy, H. Bedem, David Sivak, G. Petsko, D. Ringe, M. Wilson, J. Fraser (2014)
Crystal cryocooling distorts conformational heterogeneity in a model Michaelis complex of DHFR.Structure, 22 6
A. Prongay, Zhuyan Guo, N. Yao, J. Pichardo, T. Fischmann, C. Strickland, J. Myers, P. Weber, B. Beyer, R. Ingram, Z. Hong, W. Prosise, L. Ramanathan, S. Taremi, T. Yarosh-Tomaine, Rumin Zhang, M. Senior, Rong-Sheng Yang, B. Malcolm, A. Arasappan, F. Bennett, S. Bogen, Kevin Chen, E. Jao, Yi-Tsung Liu, R. Lovey, A. Saksena, S. Venkatraman, V. Girijavallabhan, F. Njoroge, V. Madison (2007)
Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimization.Journal of medicinal chemistry, 50 10
Cynthia Liu, Q. Zhou, Yingzhu Li, Linda Garner, Steve Watkins, L. Carter, Jeffrey Smoot, Anne Gregg, Angel Daniels, Susan Jervey, Dana Albaiu (2020)
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus DiseasesACS Central Science, 6
(1996)
Viral cysteine proteases. Perspect
Zhenming Jin, Xiaoyu Du, Yechun Xu, Yongqiang Deng, Meiqin Liu, Yao Zhao, Bing Zhang, Xiaofeng Li, Lei-ke Zhang, Chao Peng, Yinkai Duan, Jing Yu, Lin Wang, Kailin Yang, Fengjiang Liu, Ren-di Jiang, Xinglou Yang, Tian You, Xiaoce Liu, Xiuna Yang, Fang Bai, Hong Liu, Xiang Liu, L. Guddat, Wenqing Xu, Gengfu Xiao, C. Qin, Z. Shí, Hualiang Jiang, Z. Rao, Haitao Yang (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitorsNature, 582
Chen (2010)
MolProbity: all-atom structure validation for macromolecular crystallographyActa Crystallogr. D, 66
C. Kuo, Y. Chi, J. Hsu, P. Liang (2004)
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrateBiochemical and Biophysical Research Communications, 318
R. Parker (2020)
Novel coronavirus (2019-nCoV)
R. Otten, Lin Liu, L. Kenner, M. Clarkson, David Mavor, Dan Tawfik, D. Kern, J. Fraser (2017)
Rescue of conformational dynamics in enzyme catalysis by directed evolutionNature Communications, 9
Thanigaimalai Pillaiyar, M. Manickam, V. Namasivayam, Y. Hayashi, Sang-hun Jung (2016)
An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule ChemotherapyJournal of Medicinal Chemistry, 59
(2007)
Kye steps in structure-based optimization
J. Bruijne, J. Bergmann, H. Reesink, C. Weegink, R. Molenkamp, J. Schinkel, X. Tong, Jing Li, M. Treitel, E. Hughes, J. Lier, A. Vliet, H. Janssen, R. Knegt (2010)
Antiviral activity of narlaprevir combined with ritonavir and pegylated interferon in chronic hepatitis C patientsHepatology, 52
J. Fraser, H. Bedem, Avi Samelson, P. Lang, J. Holton, N. Echols, T. Alber (2011)
Accessing protein conformational ensembles using room-temperature X-ray crystallographyProceedings of the National Academy of Sciences, 108
Zhenming Jin, Yao Zhao, Yuanyuan Sun, Bing Zhang, Haofeng Wang, Yan Wu, Yan Zhu, Chen Zhu, T. Hu, Xiaoyu Du, Yinkai Duan, Jing Yu, Xiaobao Yang, Xiuna Yang, Kailin Yang, Xiang Liu, L. Guddat, Gengfu Xiao, Lei-ke Zhang, Haitao Yang, Z. Rao (2020)
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofurNature Structural & Molecular Biology, 27
Changkang Huang, P. Wei, K. Fan, Y. Liu, L. Lai (2004)
3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism.Biochemistry, 43 15
Linlin Zhang, Daizong Lin, Xinyuanyuan Sun, U. Curth, C. Drosten, Lucie Sauerhering, S. Becker, K. Rox, R. Hilgenfeld (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitorsScience (New York, N.y.), 368
Y. Rastogi, A. Sharma, R. Nagraik, A. Aygün, F. Sen (2020)
The novel coronavirus 2019-nCoV: Its evolution and transmission into humans causing global COVID-19 pandemicInternational Journal of Environmental Science and Technology, 17
Li Wang, Bo-Bo Bao, Guo-Qing Song, Cheng Chen, Xu-Meng Zhang, Wei Lu, Zefang Wang, Yan Cai, Shuang Li, Sheng Fu, Fu-Hang Song, Haitao Yang, Jian‐guo Wang (2017)
Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: Chemical synthesis, biological evaluation, molecular docking and 3D-QSAR studyEuropean Journal of Medicinal Chemistry, 137
Alexander H, A. Gorbalenya, S. Baker, R. Baric, R. Groot, C. Drosten, Anastasia Gulyaeva, B. Haagmans, C. Lauber, A. Leontovich, B. Neuman, Dmitry Penzar, S. Perlman, L. Poon, Dmitry Samborskiy, I. Sidorov, I. Sola, J. Ziebuhr (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2Nature Microbiology, 5
Yosra Helmy, M. Fawzy, Ahmed Elaswad, A. Sobieh, Scott Kenney, A. Shehata (2020)
The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and ControlJournal of Clinical Medicine, 9
Fan Wu, Su Zhao, Bin Yu, Yan-Mei Chen, Wen Wang, Zhigang Song, Y. Hu, Zhaowu Tao, Jun-hua Tian, Yuan-Yuan Pei, Mingli Yuan, Yuling Zhang, Fahui Dai, Yi Liu, Qimin Wang, Jiao-Jiao Zheng, Lin Xu, E. Holmes, Yong‐Zhen Zhang (2020)
A new coronavirus associated with human respiratory disease in ChinaNature, 579
Wenting Bu, Z. Levitskaya, Z. Loh, Shengyang Jin, S. Basu, R. Ero, Xinfu Yan, Meitian Wang, So Ngan, S. Sze, Suet-Mien Tan, Yong-Gui Gao (2020)
Data collection and refinement statistics.PLOS Biology
T. Muramatsu, C. Takemoto, Yong‐Tae Kim, Hongfei Wang, W. Nishii, T. Terada, M. Shirouzu, S. Yokoyama (2016)
SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativityProceedings of the National Academy of Sciences, 113
X. Xue, Haitao Yang, W. Shen, Qi Zhao, Jun Li, Kailin Yang, Cheng Chen, Yinghua Jin, M. Bartlam, Z. Rao (2006)
Production of Authentic SARS-CoV Mpro with Enhanced Activity: Application as a Novel Tag-cleavage Endopeptidase for Protein OverproductionJournal of Molecular Biology, 366
G. Appleyard, M. Tisdale (1985)
Inhibition of the growth of human coronavirus 229E by leupeptin.The Journal of general virology, 66 ( Pt 2)
Maria Bzówka, Karolina Mitusińska, A. Raczyńska, Aleksandra Samol, J. Tuszyński, Artur Góra (2020)
Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor DesignInternational Journal of Molecular Sciences, 21
P. Adams, P. Afonine, G. Bunkoczi, Vincent Chen, Ian Davis, Nathaniel Echols, J. Headd, Li-Wei Hung, Gary Kapral, R. Grosse-Kunstleve, A. Mccoy, N. Moriarty, R. Oeffner, Randy Read, David Richardson, Jane Richardson, T. Terwilliger, P. Zwart
Electronic Reprint Biological Crystallography Phenix : a Comprehensive Python-based System for Macromolecular Structure Solution
A. Kovalevsky, M. Aggarwal, Hector Velazquez, Matthew Cuneo, M. Blakeley, Kevin Weiss, Jeremy Smith, S. Fisher, R. McKenna (2018)
"To Be or Not to Be" Protonated: Atomic Details of Human Carbonic Anhydrase-Clinical Drug Complexes by Neutron Crystallography and Simulation.Structure, 26 3
(2016)
Pharmacokinetics of the new hapatitis C virus NS3 protease inhibitor narlapre
A. Kwong, R. Perni, C. Graham (2019)
Development and Marketing of INCIVEK (Telaprevir; VX-950): A First-Generation HCV Protease Inhibitor, in Combination with PEGylated Interferon and RibavirinTopics in Medicinal Chemistry
S. Venkatraman (2019)
Discovery of Boceprevir, a Ketoamide-Derived HCV NS3 Protease Inhibitor, for Treatment of Genotype 1 InfectionsTopics in Medicinal Chemistry
M. Winn, C. Ballard, K. Cowtan, E. Dodson, P. Emsley, P. Evans, R. Keegan, E. Krissinel, A. Leslie, A. Mccoy, Stuart McNicholas, G. Murshudov, N. Pannu, E. Potterton, H. Powell, R. Read, A. Vagin, K. Wilson (2011)
Overview of the CCP4 suite and current developmentsActa Crystallographica Section D: Biological Crystallography, 67
(2004)
research papers Acta Crystallographica Section D Biological
Jiabao Xu, Shizhe Zhao, Tieshan Teng, A. Abdalla, Wan Zhu, Longxiang Xie, Yunlong Wang, Xiangqian Guo (2020)
Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoVViruses, 12
V. Isakov, D. Koloda, N. Tikhonova, T. Kikalishvili, E. Krasavina, K. Lekishvili, I. Malaya, M. Ryska, M. Samsonov, V. Tolkacheva (2016)
Pharmacokinetics of the New Hepatitis C Virus NS3 Protease Inhibitor Narlaprevir following Single-Dose Use with or without Ritonavir in Patients with Liver CirrhosisAntimicrobial Agents and Chemotherapy, 60
P. Evans, G. Murshudov (2013)
How good are my data and what is the resolution?Acta Crystallographica Section D: Biological Crystallography, 69
Wenhao Dai, Bing Zhang, Xiaming Jiang, H. Su, Jian Li, Yao Zhao, Xiong Xie, Zhenming Jin, Jingjing Peng, Fengjiang Liu, Chunpu Li, You Li, Fang Bai, Haofeng Wang, Xi Cheng, X. Cen, Shulei Hu, Xiuna Yang, Jiang Wang, Xiang Liu, Gengfu Xiao, Hualiang Jiang, Z. Rao, Lei-ke Zhang, Yechun Xu, Haitao Yang, Hong Liu (2020)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main proteaseScience (New York, N.y.)
Structure – Unpaywall
Published: Oct 23, 2020
Access the full text.
Sign up today, get DeepDyve free for 14 days.